These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 15751737)
21. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity. Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928 [TBL] [Abstract][Full Text] [Related]
22. Mapping of nucleocapsid residues important for HIV-1 genomic RNA dimerization and packaging. Kafaie J; Song R; Abrahamyan L; Mouland AJ; Laughrea M Virology; 2008 Jun; 375(2):592-610. PubMed ID: 18343475 [TBL] [Abstract][Full Text] [Related]
23. An in vitro fluorescence screen to identify antivirals that disrupt hepatitis B virus capsid assembly. Stray SJ; Johnson JM; Kopek BG; Zlotnick A Nat Biotechnol; 2006 Mar; 24(3):358-62. PubMed ID: 16474383 [TBL] [Abstract][Full Text] [Related]
24. The requirements and mechanism for capsid assembly and budding of bovine foamy virus. Kong XH; Yu H; Xuan CH; Wang JZ; Chen QM; Geng YQ Arch Virol; 2005 Aug; 150(8):1677-84. PubMed ID: 15834655 [TBL] [Abstract][Full Text] [Related]
25. Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles. Resh MD AIDS Rev; 2005; 7(2):84-91. PubMed ID: 16092502 [TBL] [Abstract][Full Text] [Related]
29. Targeting the Early Step of Building Block Organization in Viral Capsid Assembly. Lampel A; Bram Y; Ezer A; Shaltiel-Kario R; Saad JS; Bacharach E; Gazit E ACS Chem Biol; 2015 Aug; 10(8):1785-90. PubMed ID: 25997366 [TBL] [Abstract][Full Text] [Related]
30. FAITH - Fast Assembly Inhibitor Test for HIV. Hadravová R; Rumlová M; Ruml T Virology; 2015 Dec; 486():78-87. PubMed ID: 26410239 [TBL] [Abstract][Full Text] [Related]
31. New approaches for antiviral targeting of HIV assembly. Prevelige PE J Mol Biol; 2011 Jul; 410(4):634-40. PubMed ID: 21762804 [TBL] [Abstract][Full Text] [Related]
32. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor. Lingappa JR; Lingappa VR; Reed JC Viruses; 2021 Mar; 13(3):. PubMed ID: 33802145 [TBL] [Abstract][Full Text] [Related]
34. Effects of macromolecular crowding on the inhibition of virus assembly and virus-cell receptor recognition. Rincón V; Bocanegra R; Rodríguez-Huete A; Rivas G; Mateu MG Biophys J; 2011 Feb; 100(3):738-746. PubMed ID: 21281589 [TBL] [Abstract][Full Text] [Related]
35. Capsid assembly as a point of intervention for novel anti-viral therapeutics. Lingappa VR; Hurt CR; Garvey E Curr Pharm Biotechnol; 2013; 14(5):513-23. PubMed ID: 22429134 [TBL] [Abstract][Full Text] [Related]
36. Use of heterologous expression systems to study retroviral morphogenesis. Boulanger P; Jones I Curr Top Microbiol Immunol; 1996; 214():237-60. PubMed ID: 8791730 [No Abstract] [Full Text] [Related]
37. [Assembly, budding and maturation of HIV1]. Chazal N Virologie (Montrouge); 2005 Jun; 9(3):215-227. PubMed ID: 34479421 [TBL] [Abstract][Full Text] [Related]
38. Two studies add to understanding of HIV assembly. von Bubnoff A IAVI Rep; 2009; 13(4):22-3. PubMed ID: 20225581 [No Abstract] [Full Text] [Related]
39. How long can HIV survive on environmental surfaces? LaBombardi V J Assoc Nurses AIDS Care; 1991; 2(4):39. PubMed ID: 1760552 [No Abstract] [Full Text] [Related]